Breaking Finance News

A statement released earlier today by UBS Securities about Civitas Solutions (NYSE:CIVI) bumps down the target price to $24.00

Stating a potential upside of 0.32%, UBS Securities reduced the stock price target of Civitas Solutions (NYSE:CIVI) to $24.00

Just yesterday Civitas Solutions (NYSE:CIVI) traded 1.33% higher at $18.25. Civitas Solutions’s 50-day moving average is $18.48 and its 200-day moving average is $19.57. The last closing price is down -6.59% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 43,446 shares of CIVI traded hands, down from an average trading volume of 79,881

Recent Performance Chart

Civitas Solutions (NYSE:CIVI)

Civitas Solutions has 52 week low of $15.19 and a 52 week high of $30.23 with a P/E ratio of 62.82 and has a market cap of $0.

General Information About Civitas Solutions (NYSE:CIVI)

Civitas Solutions, Inc. is a provider of home and community-based health and human services to individuals with intellectual, developmental, physical or behavioral disabilities and other special needs. The Company's clinicians and caregivers develop customized service plans, delivered in non-institutional settings, designed to address a range of often life-long conditions. The Company operates through two segments: Human Services and Post-Acute Specialty Rehabilitation Services (SRS). The Company's Human Services segment provides home and community-based human services to individuals with intellectual and/or developmental disabilities, youth with emotional, behavioral and/or medically complex challenges, or at-risk youth and elders. The Company's SRS segment delivers healthcare and community-based health and human services to individuals who have suffered acquired brain injury, spinal injuries and other catastrophic injuries and illnesses.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *